Synergy CHC Corp. (SNYR)
NASDAQ: SNYR · Real-Time Price · USD
2.160
+0.060 (2.86%)
At close: Jun 9, 2025, 4:00 PM
2.170
+0.010 (0.46%)
After-hours: Jun 9, 2025, 7:46 PM EDT
Synergy CHC Revenue
Synergy CHC had revenue of $8.17M in the quarter ending March 31, 2025, a decrease of -13.19%. This brings the company's revenue in the last twelve months to $33.59M, down -24.04% year-over-year. In the year 2024, Synergy CHC had annual revenue of $34.83M, down -18.57%.
Revenue (ttm)
$33.59M
Revenue Growth
-24.04%
P/S Ratio
0.51
Revenue / Employee
$1,599,663
Employees
21
Market Cap
19.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.83M | -7.94M | -18.57% |
| Dec 31, 2023 | 42.78M | 4.37M | 11.37% |
| Dec 31, 2022 | 38.41M | -1.82M | -4.51% |
| Dec 31, 2020 | 40.23M | 10.87M | 37.02% |
| Dec 31, 2019 | 29.36M | -4.47M | -13.21% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
SNYR News
- 5 days ago - Synergy CHC Announces New $20 Million Long-Term Credit Facility - GlobeNewsWire
- 5 weeks ago - Synergy CHC Corp. Announces First Quarter 2025 Earnings and Conference Call Information - GlobeNewsWire
- 8 months ago - U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha
- 8 months ago - Synergy CHC Corp. Announces Closing of Initial Public Offering - GlobeNewsWire
- 8 months ago - Synergy CHC Corp. Prices $10.35 Million Initial Public Offering - GlobeNewsWire
- 3 years ago - Synergy CHC Pursues $69 Million U.S. Uplisting IPO - Seeking Alpha